RETRACTED: Development of thermosensitive hydrogel of Amphotericin-B and Lactoferrin combination-loaded PLGA-PEG-PEI nanoparticles for potential eradication of ocular fungal infections: In-vitro, ex-vivo and in-vivo studies (International Journal of Pharmaceutics: X (2023) 5, (S259015672300018X), (10.1016/j.ijpx.2023.100174))

Sammar Fathy Elhabal, Shrouk A. Ghaffar, Raghda Hager, Nahla A. Elzohairy, Mohamed Mansour Khalifa, Passant M. Mohie, Rania A. Gad, Nasreen N. Omar, Mohammed H. Elkomy, Mohammad Ahmad Khasawneh, Nashwa Abdelaal

Research output: Contribution to journalComment/debatepeer-review

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/policies/article-withdrawal). This article has been retracted at the request of the Editor-in-Chief. Concern had been raised about inconsistencies in the figures and image similarities between figures. Image analysis performed by the editorial office confirmed findings of image duplications between subfigures in Figs. 9 and 10, and between Figs. 14 and 15. The authors failed to provide a satisfactory explanation during the investigation.

Original languageEnglish
Article number100270
JournalInternational Journal of Pharmaceutics: X
Volume8
DOIs
Publication statusPublished - Dec 2024

ASJC Scopus subject areas

  • Pharmaceutical Science

Fingerprint

Dive into the research topics of 'RETRACTED: Development of thermosensitive hydrogel of Amphotericin-B and Lactoferrin combination-loaded PLGA-PEG-PEI nanoparticles for potential eradication of ocular fungal infections: In-vitro, ex-vivo and in-vivo studies (International Journal of Pharmaceutics: X (2023) 5, (S259015672300018X), (10.1016/j.ijpx.2023.100174))'. Together they form a unique fingerprint.

Cite this